433 related articles for article (PubMed ID: 12244575)
21. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice.
Goumans MJ; Mummery C
Int J Dev Biol; 2000 Apr; 44(3):253-65. PubMed ID: 10853822
[TBL] [Abstract][Full Text] [Related]
22. Smad7 misexpression during embryonic angiogenesis causes vascular dilation and malformations independently of vascular smooth muscle cell function.
Vargesson N; Laufer E
Dev Biol; 2001 Dec; 240(2):499-516. PubMed ID: 11784079
[TBL] [Abstract][Full Text] [Related]
23. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
[TBL] [Abstract][Full Text] [Related]
24. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.
Halder SK; Beauchamp RD; Datta PK
Exp Cell Res; 2005 Jul; 307(1):231-46. PubMed ID: 15922743
[TBL] [Abstract][Full Text] [Related]
25. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
26. [Ski and SnoN: antagonistic proteins of TGFbeta signaling].
Vignais ML
Bull Cancer; 2000 Feb; 87(2):135-7. PubMed ID: 10705283
[TBL] [Abstract][Full Text] [Related]
27. A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3.
Dennler S; Huet S; Gauthier JM
Oncogene; 1999 Feb; 18(8):1643-8. PubMed ID: 10102636
[TBL] [Abstract][Full Text] [Related]
28. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.
Zhang S; Fei T; Zhang L; Zhang R; Chen F; Ning Y; Han Y; Feng XH; Meng A; Chen YG
Mol Cell Biol; 2007 Jun; 27(12):4488-99. PubMed ID: 17438144
[TBL] [Abstract][Full Text] [Related]
29. Differential gene expression of TGF beta inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue.
Reinholz MM; An MW; Johnsen SA; Subramaniam M; Suman VJ; Ingle JN; Roche PC; Spelsberg TC
Breast Cancer Res Treat; 2004 Jul; 86(1):75-88. PubMed ID: 15218362
[TBL] [Abstract][Full Text] [Related]
30. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements.
Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K
Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821
[TBL] [Abstract][Full Text] [Related]
31. SMAD-signaling in chronic obstructive pulmonary disease: transcriptional down-regulation of inhibitory SMAD 6 and 7 by cigarette smoke.
Springer J; Scholz FR; Peiser C; Groneberg DA; Fischer A
Biol Chem; 2004 Jul; 385(7):649-53. PubMed ID: 15318814
[TBL] [Abstract][Full Text] [Related]
32. Sequential gonadotropin treatment of immature mice leads to amplification of transforming growth factor beta action, via upregulation of receptor-type 1, Smad 2 and 4, and downregulation of Smad 6.
Guéripel X; Benahmed M; Gougeon A
Biol Reprod; 2004 Mar; 70(3):640-8. PubMed ID: 14585817
[TBL] [Abstract][Full Text] [Related]
33. Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7.
Boulay JL; Mild G; Reuter J; Lagrange M; Terracciano L; Lowy A; Laffer U; Orth B; Metzger U; Stamm B; Martinoli S; Herrmann R; Rochlitz C
Genes Chromosomes Cancer; 2001 Jul; 31(3):240-7. PubMed ID: 11391794
[TBL] [Abstract][Full Text] [Related]
34. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP; Mikkola D; Willson JK; Markowitz S
Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
[TBL] [Abstract][Full Text] [Related]
35. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
36. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG
J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365
[TBL] [Abstract][Full Text] [Related]
37. TGFbeta and BMP-2 activation of the OPN promoter: roles of smad- and hox-binding elements.
Hullinger TG; Pan Q; Viswanathan HL; Somerman MJ
Exp Cell Res; 2001 Jan; 262(1):69-74. PubMed ID: 11120606
[TBL] [Abstract][Full Text] [Related]
38. A molecular basis for Smad specificity.
Lagna G; Hemmati-Brivanlou A
Dev Dyn; 1999 Mar; 214(3):269-77. PubMed ID: 10090153
[TBL] [Abstract][Full Text] [Related]
39. Structural insights on Smad function in TGFbeta signaling.
Shi Y
Bioessays; 2001 Mar; 23(3):223-32. PubMed ID: 11223879
[TBL] [Abstract][Full Text] [Related]
40. Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma.
Takagawa S; Lakos G; Mori Y; Yamamoto T; Nishioka K; Varga J
J Invest Dermatol; 2003 Jul; 121(1):41-50. PubMed ID: 12839562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
